17 alpha-hydroxyprogesterone caproate has been researched along with Adverse Drug Event in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anguiano, RH; Bobowski, C; Mastrogiannis, D; Milikhiker, N; Stone, RH | 1 |
1 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Adverse Drug Event
| Article | Year |
|---|---|
Prevention of Preterm Labor with 17α-Hydroxyprogesterone (17OHP) Caproate: A Comparison of Adverse Drug Reaction Rates between Compounded and Commercial Formulations.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Drug Compounding; Drug-Related Side Effects and Adverse Reactions; Female; Gestational Age; Humans; Hydroxyprogesterones; Medication Adherence; Pregnancy; Premature Birth; Retrospective Studies; Young Adult | 2017 |